Compare UBC Medical Indonesia Tbk. (LABS) vs Pelat Timah Nusantara Tbk. (NIKL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UBC Medical Indonesia Tbk. vs Pelat Timah Nusantara Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp165 (market cap 651.75B), while Pelat Timah Nusantara Tbk. trades at Rp190 (market cap 479.44B). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| LABS | NIKL | |
|---|---|---|
Market Cap | 651.75B | 479.44B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →About Pelat Timah Nusantara Tbk.
PT Pelat Timah Nusantara Tbk (PT Latinusa) was the first company in Indonesia that produces high-quality tinplate with international standards. PT Latinusa was founded on August 19, 1982 under the Company Act No.45, drawn up before Imas Fatimah, SH, and the current majority shareholder is the Japanese consortium consisting of Nippon Steel Corporation, Mitsui Co.. Ltd.., Nippon Steel Trading Co.., And Metal One. Nippon Steel Corporation is also the provider of our main raw material, Tin Mill Black Plate (TMBP), so the availability of raw materials is always guaranteed.
Read more on NIKL →
